|
AU2006332726B2
(en)
|
2005-12-28 |
2012-12-13 |
Vertex Pharmaceuticals Incorporated. |
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
KR101653842B1
(ko)
|
2008-01-04 |
2016-09-02 |
인텔리카인, 엘엘씨 |
특정 화학 물질, 조성물 및 방법
|
|
PE20120493A1
(es)
|
2009-06-29 |
2012-05-20 |
Incyte Corp |
Pirimidinonas como inhibidores de pi3k
|
|
US8759359B2
(en)
|
2009-12-18 |
2014-06-24 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as PI3K inhibitors
|
|
US20130018039A1
(en)
*
|
2010-03-31 |
2013-01-17 |
Bodmer Vera Q |
Imidazolyl-imidazoles as kinase inhibitors
|
|
AR081823A1
(es)
|
2010-04-14 |
2012-10-24 |
Incyte Corp |
DERIVADOS FUSIONADOS COMO INHIBIDORES DE PI3Kd
|
|
WO2011163195A1
(en)
|
2010-06-21 |
2011-12-29 |
Incyte Corporation |
Fused pyrrole derivatives as pi3k inhibitors
|
|
JP5937102B2
(ja)
*
|
2010-12-14 |
2016-06-22 |
エレクトロフォレティクス リミテッド |
カゼインキナーゼ１デルタ（ｃｋ１デルタ）阻害剤
|
|
ES2764848T3
(es)
|
2010-12-20 |
2020-06-04 |
Incyte Holdings Corp |
N-(1-(fenilo sustituido)etilo)-9H-purina-6-aminas como inhibidores de PI3K
|
|
WO2012088266A2
(en)
|
2010-12-22 |
2012-06-28 |
Incyte Corporation |
Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
|
|
AR084824A1
(es)
|
2011-01-10 |
2013-06-26 |
Intellikine Inc |
Procesos para preparar isoquinolinonas y formas solidas de isoquinolinonas
|
|
GB201104267D0
(en)
|
2011-03-14 |
2011-04-27 |
Cancer Rec Tech Ltd |
Pyrrolopyridineamino derivatives
|
|
WO2012125629A1
(en)
|
2011-03-14 |
2012-09-20 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
|
|
WO2012135009A1
(en)
|
2011-03-25 |
2012-10-04 |
Incyte Corporation |
Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
|
|
AR087701A1
(es)
|
2011-08-31 |
2014-04-09 |
Japan Tobacco Inc |
Derivados de pirazol con actividad inhibidora de sglt1
|
|
KR20230038593A
(ko)
|
2011-09-02 |
2023-03-20 |
인사이트 홀딩스 코포레이션 |
Ｐｉ３ｋ 억제제로서 헤테로시클릴아민
|
|
JP6117191B2
(ja)
|
2011-10-07 |
2017-04-19 |
武田薬品工業株式会社 |
神経変性疾患の治療に有用な１−アリールカルボニル−４−オキシ−ピペリジン化合物
|
|
AU2012327076B2
(en)
|
2011-10-18 |
2017-07-06 |
Astellas Pharma Inc. |
Bicyclic heterocyclic compound
|
|
AR090037A1
(es)
|
2011-11-15 |
2014-10-15 |
Xention Ltd |
Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
|
|
ES2652664T3
(es)
|
2011-12-01 |
2018-02-05 |
Chemocentryx, Inc. |
Anilinas sustituidas como antagonistas de CCR(4)
|
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
|
HUE042374T2
(hu)
|
2012-06-13 |
2019-06-28 |
Incyte Holdings Corp |
Szubsztituált triciklusos vegyületek mint FGFR inhibitorok
|
|
TWI633087B
(zh)
|
2012-06-13 |
2018-08-21 |
赫孚孟拉羅股份公司 |
新穎二氮雜螺環烷及氮雜螺環烷
|
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
|
WO2014007228A1
(ja)
|
2012-07-03 |
2014-01-09 |
小野薬品工業株式会社 |
ソマトスタチン受容体作動活性を有する化合物およびその医薬用途
|
|
WO2014009891A1
(en)
*
|
2012-07-11 |
2014-01-16 |
Piramal Enterprises Limited |
Heterocyclic compounds for use in the treatment of cancers
|
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
|
CA2881554C
(en)
|
2012-08-22 |
2022-01-04 |
Cornell University |
Methods for inhibiting fascin
|
|
BR112015003824B1
(pt)
*
|
2012-08-24 |
2022-10-04 |
Treventis Corporation |
Composto, composição farmacêutica e uso do composto
|
|
CN102850341B
(zh)
*
|
2012-09-05 |
2015-02-18 |
浙江工业大学 |
一种噻二唑类化合物及其制备与应用
|
|
GB201216018D0
(en)
|
2012-09-07 |
2012-10-24 |
Cancer Rec Tech Ltd |
Pharmacologically active compounds
|
|
RS59512B1
(sr)
|
2012-09-25 |
2019-12-31 |
Hoffmann La Roche |
Derivati heksahidropirolo[3,4−c]pirola i srodna jedinjenja kao inhibitori autotaksina (atx) i kao inhibitori proizvodnje lizofosfatidne kiseline (lpa) za lečenje npr. bubrežnih bolesti
|
|
CN103739594A
(zh)
*
|
2012-10-17 |
2014-04-23 |
南京大学 |
一类含吡嗪环和三氮唑结构的席夫碱类衍生物及其制法
|
|
WO2014071109A1
(en)
|
2012-11-01 |
2014-05-08 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using pi3 kinase isoform modulators
|
|
KR102194646B1
(ko)
|
2012-11-27 |
2020-12-23 |
토마스 헬데이스 스티프텔스 퓌어 메디신스크 포르스닝 |
암 치료를 위한 피리미딘-2,4-다이아민 유도체
|
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
|
WO2014103801A1
(ja)
|
2012-12-28 |
2014-07-03 |
株式会社新日本科学 |
イミダゾピリジン誘導体を有効成分として含むｏｃｔ３活性阻害剤又はｏｃｔ３検出剤
|
|
CA2900779C
(en)
|
2013-02-11 |
2021-10-26 |
The Regents Of The University Of California |
Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
|
|
AR095079A1
(es)
|
2013-03-12 |
2015-09-16 |
Hoffmann La Roche |
Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
|
|
US9790188B2
(en)
|
2013-03-15 |
2017-10-17 |
Whitehead Institute For Biomedical Research |
Benzimidazole derivatives and uses thereof
|
|
WO2014144747A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
US9045477B2
(en)
|
2013-03-15 |
2015-06-02 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
KR102469849B1
(ko)
|
2013-04-19 |
2022-11-23 |
인사이트 홀딩스 코포레이션 |
Fgfr 저해제로서 이환식 헤테로사이클
|
|
US9797882B2
(en)
|
2013-07-09 |
2017-10-24 |
The Translational Genomics Research Institute |
Method of screening for a compound for inhibitory activity of FN14-tweak interaction
|
|
WO2015006508A2
(en)
|
2013-07-09 |
2015-01-15 |
The Translational Genomics Research Institute |
Compositions and methods of screening for compounds that modulate activity at a tweak binding site on a crd of fn14
|
|
TWI649308B
(zh)
|
2013-07-24 |
2019-02-01 |
小野藥品工業股份有限公司 |
喹啉衍生物
|
|
GB201314452D0
(en)
|
2013-08-13 |
2013-09-25 |
Ostara Biomedical Ltd |
Embryo implantation
|
|
RU2570907C2
(ru)
*
|
2013-10-21 |
2015-12-20 |
Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" |
Производные 3-ациламинопиридин-2(1h)-она, применимые как ингибиторы серин-треониновой протеинкиназы gsk3b в качестве лекарственных препаратов для лечения диабета ii типа.
|
|
EP3071206B1
(en)
|
2013-11-22 |
2021-02-17 |
CL Biosciences LLC |
Gastrin antagonists (eg yf476, netazepide) for treatment and prevention of osteoporosis
|
|
WO2015078803A1
(en)
|
2013-11-26 |
2015-06-04 |
F. Hoffmann-La Roche Ag |
NEW OCTAHYDRO-CYCLOBUTA [1,2-c;3,4-c']DIPYRROL-2-YL
|
|
GB201321738D0
(en)
*
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic Agents
|
|
US10087151B2
(en)
|
2014-01-09 |
2018-10-02 |
The J. David Gladstone Institutes, A Testimentary Trust Established Under The Will Of J. David Gladstone |
Substituted benzoxazine and related compounds
|
|
PE20161443A1
(es)
|
2014-01-29 |
2017-01-06 |
Glaxosmithkline Ip Dev Ltd |
Compuestos
|
|
US9815841B2
(en)
|
2014-01-29 |
2017-11-14 |
Glaxosmithkline Intellectual Property Development Limited |
Compounds
|
|
US10167286B2
(en)
|
2014-02-11 |
2019-01-01 |
Mitokinin, Inc. |
Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
|
|
WO2015123408A1
(en)
|
2014-02-13 |
2015-08-20 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
TWI664164B
(zh)
|
2014-02-13 |
2019-07-01 |
美商英塞特控股公司 |
作為ｌｓｄ１抑制劑之環丙胺
|
|
WO2015123437A1
(en)
|
2014-02-13 |
2015-08-20 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
PE20161573A1
(es)
|
2014-02-13 |
2017-01-19 |
Incyte Corp |
Ciclopropilamina como inhibidor de la lsd1
|
|
DK3107902T3
(da)
|
2014-02-20 |
2021-05-03 |
Cornell Univ Cornell Center For Technology Enterprise & Commercialization Cctec |
Forbindelser og fremgangsmåder til at hæmme fascin
|
|
HRP20191150T1
(hr)
|
2014-02-27 |
2019-10-04 |
Treventis Corporation |
Antiamiloidni spojevi koji sadrže benzofuran
|
|
CN106103446B
(zh)
|
2014-03-26 |
2019-07-30 |
豪夫迈·罗氏有限公司 |
作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的二环化合物
|
|
KR20160128428A
(ko)
|
2014-03-26 |
2016-11-07 |
에프. 호프만-라 로슈 아게 |
오토탁신(atx) 및 리소포스파티드산(lpa) 생성 억제제로서의 축합형 [1,4]다이아제핀 화합물
|
|
WO2015157382A1
(en)
*
|
2014-04-11 |
2015-10-15 |
Emory University |
Treatment of neurodegenerative diseases with asparagine endopeptidase (aep) inhibitors and compositions related thereto
|
|
WO2015160975A2
(en)
|
2014-04-16 |
2015-10-22 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
CN105085436B
(zh)
*
|
2014-04-19 |
2019-08-16 |
广东东阳光药业有限公司 |
磺酰胺类衍生物及其在药物上的应用
|
|
MA50375A
(fr)
*
|
2014-04-23 |
2021-05-26 |
Dart Neuroscience Cayman Ltd |
Compositions contenant des composés substitués de [1,2,4]triazolo[1,5-a]pyrimidine-7-yl utilisés en tant qu'inhibiteurs pde2
|
|
WO2015170218A1
(en)
|
2014-05-07 |
2015-11-12 |
Pfizer Inc. |
Tropomyosin-related kinase inhibitors
|
|
CN104059060B
(zh)
*
|
2014-05-30 |
2017-08-01 |
西安交通大学 |
一种5‑(1h‑吲哚‑3‑亚甲基)‑1,3‑噻唑烷‑4‑酮类衍生物及其合成方法和应用
|
|
AU2015268962A1
(en)
|
2014-06-04 |
2017-01-12 |
Thomas Helledays Stiftelse For Medicinsk Forskning |
MTH1 inhibitors for treatment of inflammatory and autoimmune conditions
|
|
CA2949785A1
(en)
|
2014-06-04 |
2015-12-10 |
Thomas Helledays Stiftelse For Medicinsk Forskning |
Mth1 inhibitors for treatment of cancer
|
|
WO2015191677A1
(en)
|
2014-06-11 |
2015-12-17 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
|
|
US9758523B2
(en)
|
2014-07-10 |
2017-09-12 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as LSD1 inhibitors
|
|
US9695180B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
|
|
WO2016007722A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
US9695168B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors
|
|
US9546166B2
(en)
|
2014-07-31 |
2017-01-17 |
Merck Patent Gmbh |
Indolizine derivatives and their use in neurodegenerative diseases
|
|
US20170204089A1
(en)
|
2014-08-04 |
2017-07-20 |
Drexel University |
Novel compounds and methods of treating or ameliorating an il-1r-mediated disease or disorder using same
|
|
JO3589B1
(ar)
|
2014-08-06 |
2020-07-05 |
Novartis Ag |
مثبطات كيناز البروتين c وطرق استخداماتها
|
|
CN107250113B
(zh)
|
2014-10-07 |
2019-03-29 |
弗特克斯药品有限公司 |
囊性纤维化跨膜传导调节蛋白的调节剂的共晶
|
|
US10851105B2
(en)
|
2014-10-22 |
2020-12-01 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
|
GB201419579D0
(en)
|
2014-11-03 |
2014-12-17 |
Iomet Pharma Ltd |
Pharmaceutical compound
|
|
WO2016073424A1
(en)
|
2014-11-05 |
2016-05-12 |
Dart Neuroscience, Llc |
Substituted 5-methyl-[1, 2, 4] triazolo [1,5-a) pyrimidin-2-amine compounds as pde2 inhibitors
|
|
EP3239147B9
(en)
|
2014-12-25 |
2020-01-08 |
Ono Pharmaceutical Co., Ltd. |
Quinoline derivative
|
|
GB201501302D0
(en)
|
2015-01-27 |
2015-03-11 |
Ostara Biomedical Ltd |
Embryo implantation
|
|
WO2016134294A1
(en)
|
2015-02-20 |
2016-08-25 |
Incyte Corporation |
Bicyclic heterocycles as fgfr4 inhibitors
|
|
AU2016219822B2
(en)
|
2015-02-20 |
2020-07-09 |
Incyte Holdings Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
|
PH12017501538B1
(en)
|
2015-02-27 |
2024-02-14 |
Incyte Holdings Corp |
Salts of p13k inhibitor and processes for their preparation
|
|
US10722513B2
(en)
|
2015-03-23 |
2020-07-28 |
The University Of Melbourne |
Treatment of respiratory diseases
|
|
MY191796A
(en)
|
2015-04-03 |
2022-07-15 |
Incyte Corp |
Heterocyclic compounds as lsd1 inhibitors
|
|
MA41898A
(fr)
|
2015-04-10 |
2018-02-13 |
Hoffmann La Roche |
Dérivés de quinazolinone bicyclique
|
|
WO2016176420A1
(en)
*
|
2015-04-30 |
2016-11-03 |
Musc Foundation For Research Development |
Oxindole compounds and pharmaceutical compositions thereof
|
|
US9988401B2
(en)
|
2015-05-11 |
2018-06-05 |
Incyte Corporation |
Crystalline forms of a PI3K inhibitor
|
|
US9732097B2
(en)
|
2015-05-11 |
2017-08-15 |
Incyte Corporation |
Process for the synthesis of a phosphoinositide 3-kinase inhibitor
|
|
GB201508276D0
(en)
|
2015-05-14 |
2015-06-24 |
Electrophoretics Ltd |
A casein kinase 1 delta inhibitor
|
|
GB201509134D0
(en)
|
2015-05-28 |
2015-07-15 |
Electrophoretics Ltd |
Biomolecules involved in Alzheimer's disease
|
|
JP6707630B2
(ja)
*
|
2015-06-01 |
2020-06-10 |
バンタム、ファーマシューティカル、リミテッド、ライアビリティー、カンパニーＢａｎｔａｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌ， Ｌｌｃ |
置換ピラゾールおよびピロール化合物、および翻訳開始の阻害およびこれらに関連する疾患および障害の治療のためにこれらを用いる方法
|
|
WO2016202758A1
(en)
|
2015-06-18 |
2016-12-22 |
Bayer Pharma Aktiengesellschaft |
Substituted 2-(1h-pyrazol-1-yl)-1h-benzimidazole compounds
|
|
WO2016202756A1
(en)
|
2015-06-18 |
2016-12-22 |
Bayer Pharma Aktiengesellschaft |
Substituted 2-(1h-pyrazol-1-yl)-1h-benzimidazole compounds
|
|
US10167270B2
(en)
|
2015-07-01 |
2019-01-01 |
Northwestern University |
Substituted quinazoline compounds and uses thereof for modulating glucocerebrosidase activity
|
|
WO2017000277A1
(en)
*
|
2015-07-01 |
2017-01-05 |
Merck Sharp & Dohme Corp. |
Substituted triazolo bicycliccompounds as pde2 inhibitors
|
|
KR102710120B1
(ko)
|
2015-08-12 |
2024-09-27 |
인사이트 홀딩스 코포레이션 |
Lsd1 저해제의 염
|
|
CN105061462B
(zh)
*
|
2015-08-18 |
2017-05-24 |
沈阳药科大学 |
含有酰胺的四氢苯并[4,5]噻吩并[2,3‑d]嘧啶类化合物及其应用
|
|
CN108026077B
(zh)
|
2015-09-04 |
2021-11-05 |
豪夫迈·罗氏有限公司 |
苯氧基甲基衍生物
|
|
KR20180052635A
(ko)
|
2015-09-18 |
2018-05-18 |
가켄 세이야쿠 가부시키가이샤 |
바이아릴 유도체 및 이를 포함하는 약제
|
|
PE20180461A1
(es)
|
2015-09-24 |
2018-03-06 |
Hoffmann La Roche |
Nuevos compuestos biciclicos como inhibidores de la atx
|
|
EP3353178B1
(en)
|
2015-09-24 |
2021-07-14 |
F. Hoffmann-La Roche AG |
Bicyclic compounds as dual atx/ca inhibitors
|
|
CR20180143A
(es)
|
2015-09-24 |
2018-05-03 |
Hoffmann La Roche |
Nuevos compuestos biciclicos como inhibidores duales de atx/ca
|
|
KR20180054635A
(ko)
|
2015-09-24 |
2018-05-24 |
에프. 호프만-라 로슈 아게 |
오토탁신(atx) 억제제로서 이환형 화합물
|
|
GB201517523D0
(en)
|
2015-10-05 |
2015-11-18 |
Ostara Biomedical Ltd |
Methods and compositions for managing reproduction
|
|
MX2018004109A
(es)
*
|
2015-10-05 |
2018-09-27 |
Univ Columbia |
Activadores de flujo autofágico y fosfolipasa d y depuración de acumulaciones de proteína que incluyen tau y tratamiento de proteinopatías.
|
|
WO2017063966A1
(en)
|
2015-10-13 |
2017-04-20 |
Bayer Pharma Aktiengesellschaft |
Substituted 2-(1h-pyrazol-1-yl)-benzothiazole compounds
|
|
SG11201803605YA
(en)
*
|
2015-11-02 |
2018-05-30 |
Janssen Pharmaceutica Nv |
[1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-7-YL COMPOUND
|
|
RU2715229C2
(ru)
*
|
2015-12-07 |
2020-02-26 |
Хинова Фармасьютикалс Инк. |
Хинолиновые соединения, способы их получения и их применения в качестве лекарственного средства, ингибирующего транспортер уратов
|
|
US20200375996A1
(en)
*
|
2015-12-15 |
2020-12-03 |
D.E. Shaw Research, Llc |
Method of treating neurodegenerative disorders by rescuing alpha-synuclein toxicity
|
|
CN107033087B
(zh)
*
|
2016-02-04 |
2020-09-04 |
西华大学 |
1h-吲唑-4-胺类化合物及其作为ido抑制剂的用途
|
|
CN107840826B
(zh)
*
|
2016-09-19 |
2021-07-09 |
西华大学 |
1h-吲唑类衍生物及其作为ido抑制剂的用途
|
|
WO2017133258A1
(zh)
*
|
2016-02-04 |
2017-08-10 |
西华大学 |
1h-吲唑类衍生物及其作为ido抑制剂的用途
|
|
PE20190377A1
(es)
|
2016-04-22 |
2019-03-08 |
Incyte Corp |
Formulaciones de un inhibidor de lsd 1
|
|
CA3026149A1
(en)
|
2016-06-02 |
2017-12-07 |
Cadent Therapeutics, Inc. |
Potassium channel modulators
|
|
CN109311848B
(zh)
|
2016-06-07 |
2022-02-01 |
北京加科思新药研发有限公司 |
可用作shp2抑制剂的新型杂环衍生物
|
|
RU2754507C2
(ru)
|
2016-06-24 |
2021-09-02 |
Инфинити Фармасьютикалз, Инк. |
Комбинированная терапия
|
|
MX2019000536A
(es)
|
2016-07-14 |
2019-04-01 |
Pfizer |
Nuevas pirimidinas carboxamidas como inhibidores de enzima vanina-1.
|
|
ES2901059T3
(es)
*
|
2016-08-09 |
2022-03-21 |
Zincure Corp |
Composición farmacéutica para el tratamiento de apoplejía basado en la inhibición de AMPK
|
|
AU2017311691B2
(en)
|
2016-08-18 |
2021-12-02 |
Vidac Pharma Ltd. |
Piperazine derivatives, pharmaceutical compositions and methods of use thereof
|
|
MX394958B
(es)
|
2016-09-02 |
2025-03-24 |
Cyclerion Therapeutics Inc |
Estimuladores de guanilato ciclasa soluble (sgc) biciclicos fusionados
|
|
CN106432235B
(zh)
*
|
2016-10-19 |
2018-02-02 |
南通大学 |
靶向CDK和DNA的β‑咔啉衍生物及其制备方法和医药用途
|
|
MA46589A
(fr)
|
2016-10-24 |
2019-08-28 |
Yumanity Therapeutics Inc |
Composés et utilisations de ces derniers
|
|
CN109937202B
(zh)
|
2016-11-02 |
2022-12-30 |
詹森药业有限公司 |
作为pde2抑制剂的[1,2,4]三唑并[1,5-a]嘧啶化合物
|
|
MX385576B
(es)
*
|
2016-11-02 |
2025-03-18 |
Janssen Pharmaceutica Nv |
Derivados de [1,2,4]triazol[1,5-a]pirimidina como inhibidores de pde2
|
|
BR112019008604A2
(pt)
|
2016-11-02 |
2019-07-09 |
Janssen Pharmaceutica Nv |
compostos de [1,2,4]triazolo[1,5-a]pirimidina como inibidores de pde2
|
|
WO2018089967A1
(en)
|
2016-11-14 |
2018-05-17 |
Virginia Commonwealth University |
Inhibitors of cancer invasion, attachment, and/or metastasis
|
|
EP3541378A4
(en)
*
|
2016-11-16 |
2020-10-07 |
University of South Florida |
ALLOSTERIC ANTAGONISTS OF GPRC6A AND THEIR USE IN THE MITIGATION OF PROTEINOPATHIES
|
|
KR20190108118A
(ko)
|
2017-01-06 |
2019-09-23 |
유마니티 테라퓨틱스, 인크. |
신경계 장애의 치료를 위한 방법
|
|
WO2018130537A1
(en)
*
|
2017-01-10 |
2018-07-19 |
ETH Zürich |
Cell-protective compounds and their use
|
|
CN106831573B
(zh)
*
|
2017-01-23 |
2019-05-24 |
南阳师范学院 |
(n-1,2,3,4-四氢异喹啉基)-阿魏酰胺化合物、制备方法及其应用
|
|
CN106748969B
(zh)
*
|
2017-01-23 |
2019-06-18 |
南阳师范学院 |
一种n-(4-苄基哌啶基)-阿魏酰胺化合物、制备方法及其用途
|
|
BR112019014814B1
(pt)
|
2017-01-23 |
2024-03-12 |
Novartis Ag |
Compostos, composições farmacêuticas dos mesmos e seus usos no tratamento de doenças associadas à disfunção de canais iônicos de potássio
|
|
CA3051605C
(en)
|
2017-01-26 |
2024-06-25 |
Ono Pharmaceutical Co., Ltd. |
Ethane-sulfonate salt of quinoline derivative
|
|
MX394556B
(es)
|
2017-02-01 |
2025-03-24 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Derivados de n1-(4-(5-(ciclopropilmetil)-1-metil-1h-pirazol-4-il) piridin-2-il) ciclohexano-1,4-diamina y compuestos relacionados como inhibidores de ck1 y/o irak1 para tratar cáncer.
|
|
CN109730996B
(zh)
*
|
2017-03-01 |
2021-08-24 |
浙江大学 |
喹啉结构类型雄激素受体拮抗剂及其应用
|
|
CN110382484B
(zh)
|
2017-03-16 |
2022-12-06 |
豪夫迈·罗氏有限公司 |
新的作为atx抑制剂的二环化合物
|
|
RU2019132254A
(ru)
|
2017-03-16 |
2021-04-16 |
Ф. Хоффманн-Ля Рош Аг |
Гетероциклические соединения, пригодные в качестве дуальных ингибиторов atx/ca
|
|
KR102007135B1
(ko)
|
2017-03-20 |
2019-08-02 |
포르마 세라퓨틱스 인크. |
피루베이트 키나제 (pkr) 활성화제로서의 피롤로피롤 조성물
|
|
SMT202400385T1
(it)
|
2017-03-23 |
2024-11-15 |
Jacobio Pharmaceuticals Co Ltd |
Nuovi derivati eterociclici utili come inibitori di shp2
|
|
MX2021011775A
(es)
|
2017-04-26 |
2023-01-10 |
Basilea Pharm Int Ag |
Procesos para la preparacion de furazanobencimidazoles y formas cristalinas de estos.
|
|
EP3634406B1
(en)
*
|
2017-05-12 |
2023-09-06 |
Board of Trustees of The Southern Illinois University on behalf of Southern Illinois University Edwardsville |
3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof
|
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
|
JOP20190282A1
(ar)
|
2017-06-09 |
2019-12-05 |
Novartis Ag |
مركبات وتركيبات لحث تكوّن الغضاريف
|
|
CA3067086A1
(en)
*
|
2017-06-14 |
2018-12-20 |
European Molecular Biology Laboratory |
Benzofuran amides and heteroaromatic analogues thereof for use in therapy
|
|
AU2018290225A1
(en)
|
2017-06-21 |
2020-01-23 |
Mitokinin, Inc. |
Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
|
|
GB201710851D0
(en)
*
|
2017-07-06 |
2017-08-23 |
Galápagos Nv |
Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
|
|
US10357489B2
(en)
|
2017-07-10 |
2019-07-23 |
Celgene Corporation |
Antiproliferative compounds and methods of use thereof
|
|
ES3008911T3
(en)
|
2017-07-11 |
2025-03-25 |
Vertex Pharma |
Carboxamides as modulators of sodium channels
|
|
EP3683212B1
(en)
*
|
2017-09-11 |
2025-11-05 |
Hodogaya Chemical Co., Ltd. |
Compound having pyrimidine ring structure and organic electroluminescent element
|
|
TWI846350B
(zh)
|
2017-09-15 |
2024-06-21 |
美商佛瑪治療公司 |
作為ＣＢＰ／ｐ３００抑制劑之四氫－咪唑並喹啉化合物
|
|
EP3695839A4
(en)
|
2017-10-13 |
2021-07-14 |
ONO Pharmaceutical Co., Ltd. |
THERAPEUTIC AGENT WITH AXL INHIBITOR AS AN ACTIVE INGREDIENT FOR SOLID TUMORS
|
|
WO2019079578A1
(en)
|
2017-10-19 |
2019-04-25 |
Amgen Inc. |
BENZIMIDAZOLE DERIVATIVES AND USES THEREOF
|
|
US11873298B2
(en)
|
2017-10-24 |
2024-01-16 |
Janssen Pharmaceutica Nv |
Compounds and uses thereof
|
|
WO2019123375A1
(en)
*
|
2017-12-21 |
2019-06-27 |
Gliapharm Sa |
Compositions and methods of treatment for neurological disorders comprising motor neuron diseases
|
|
JP2021507945A
(ja)
*
|
2017-12-21 |
2021-02-25 |
グリアファーム エスエー |
認知症を含む神経障害のための組成物および治療方法
|
|
WO2019168847A1
(en)
|
2018-02-27 |
2019-09-06 |
Incyte Corporation |
Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors
|
|
US20210040074A1
(en)
*
|
2018-03-06 |
2021-02-11 |
The United States Of America,As Represented By The Secretary,Department Of Health And Human Services |
Positive allosteric modulators of dopamine 1 receptor and method of use thereof
|
|
EP3543231A1
(en)
*
|
2018-03-19 |
2019-09-25 |
ETH Zurich |
Compounds for treating cns- and neurodegenerative diseases
|
|
MX2020009942A
(es)
|
2018-03-23 |
2021-01-08 |
Yumanity Therapeutics Inc |
Compuestos y usos de los mismos.
|
|
EP4309737A3
(en)
|
2018-05-04 |
2024-03-27 |
Incyte Corporation |
Solid forms of an fgfr inhibitor and processes for preparing the same
|
|
EP3788046B1
(en)
|
2018-05-04 |
2025-12-10 |
Incyte Corporation |
Salts of an fgfr inhibitor
|
|
TWI815887B
(zh)
*
|
2018-05-15 |
2023-09-21 |
美商愛彼特生物製藥股份有限公司 |
經取代的2,2'-雙嘧啶基化合物、其類似物及其使用方法
|
|
US11168089B2
(en)
|
2018-05-18 |
2021-11-09 |
Incyte Corporation |
Fused pyrimidine derivatives as A2A / A2B inhibitors
|
|
CN112469418A
(zh)
|
2018-06-01 |
2021-03-09 |
因赛特公司 |
治疗pi3k相关病症的给药方案
|
|
GB201810092D0
(en)
|
2018-06-20 |
2018-08-08 |
Ctxt Pty Ltd |
Compounds
|
|
GB201810581D0
(en)
|
2018-06-28 |
2018-08-15 |
Ctxt Pty Ltd |
Compounds
|
|
MX2023013508A
(es)
|
2018-06-29 |
2023-12-13 |
Forma Therapeutics Inc |
Inhibicion de la proteina de union a creb (cbp).
|
|
JOP20200342A1
(ar)
|
2018-07-05 |
2020-12-30 |
Incyte Corp |
مشتقات بيرازين مدمجة كمثبطات a2a/a2b
|
|
KR20210068399A
(ko)
*
|
2018-08-06 |
2021-06-09 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 주니어 유니버시티 |
신경퇴행성 질병의 치료를 위한 피피에이알지씨1알파 활성제로서 2-아릴벤즈이미다졸
|
|
US11446289B2
(en)
|
2018-08-29 |
2022-09-20 |
Chemocentryx, Inc. |
Combination therapy using C-C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors
|
|
US10968200B2
(en)
|
2018-08-31 |
2021-04-06 |
Incyte Corporation |
Salts of an LSD1 inhibitor and processes for preparing the same
|
|
US11278527B2
(en)
|
2018-09-04 |
2022-03-22 |
Brown University |
Compositions and methods for the modulation of the corticotropin releasing factor binding protein and the treatment of alcohol use disorder
|
|
WO2020061103A1
(en)
|
2018-09-18 |
2020-03-26 |
Nikang Therapeutics, Inc. |
Fused tricyclic ring derivatives as src homology-2 phosphatase inhibitors
|
|
US20200129485A1
(en)
|
2018-09-19 |
2020-04-30 |
Forma Therapeutics, Inc. |
Treating sickle cell disease with a pyruvate kinase r activating compound
|
|
EP3852791B1
(en)
|
2018-09-19 |
2024-07-03 |
Novo Nordisk Health Care AG |
Activating pyruvate kinase r
|
|
US20210393623A1
(en)
|
2018-09-26 |
2021-12-23 |
Jacobio Pharmaceuticals Co., Ltd. |
Novel Heterocyclic Derivatives Useful as SHP2 Inhibitors
|
|
CA3116339A1
(en)
|
2018-10-22 |
2020-04-30 |
Cadent Therapeutics, Inc. |
Crystalline forms of potassium channel modulators
|
|
CA3113805C
(en)
*
|
2018-10-23 |
2023-03-28 |
Daiichi Sankyo Company, Limited |
Biaryl derivative
|
|
AU2019374731B2
(en)
|
2018-11-07 |
2025-08-21 |
Tianli Biotech Pty Ltd |
Compounds and compositions for the treatment of respiratory diseases
|
|
CN109503563B
(zh)
*
|
2018-12-10 |
2020-05-12 |
济南大学 |
多功能乙酰胆碱酯酶抑制剂及其应用
|
|
KR102128509B1
(ko)
*
|
2018-12-19 |
2020-07-01 |
한국과학기술연구원 |
말단 아민기에 아릴 또는 헤테로아릴기가 치환된 신규한 히드라존 유도체 및 이의 용도
|
|
CN113286785A
(zh)
*
|
2019-01-04 |
2021-08-20 |
贝尔布鲁克实验室有限责任公司 |
作为治疗剂的cGAS活性的抑制剂
|
|
WO2020146612A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
WO2020146682A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
KR20220007845A
(ko)
|
2019-01-24 |
2022-01-19 |
유마니티 테라퓨틱스, 인크. |
화합물 및 이의 용도
|
|
TWI829857B
(zh)
|
2019-01-29 |
2024-01-21 |
美商英塞特公司 |
作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶
|
|
US11628162B2
(en)
|
2019-03-08 |
2023-04-18 |
Incyte Corporation |
Methods of treating cancer with an FGFR inhibitor
|
|
TW202102494A
(zh)
|
2019-03-15 |
2021-01-16 |
美商弗瑪治療公司 |
抑制環amp-反應元件-結合蛋白(creb)
|
|
KR20220027822A
(ko)
|
2019-04-26 |
2022-03-08 |
셀진 코포레이션 |
헤테로시클릭 화합물 및 연충 감염 및 질환의 치료를 위한 그의 용도
|
|
UY38687A
(es)
|
2019-05-17 |
2023-05-15 |
Novartis Ag |
Inhibidores del inflamasoma nlrp3, composiciones, combinaciones de los mismos y métodos para su uso
|
|
EP3986890B9
(en)
|
2019-06-18 |
2025-04-16 |
Pfizer Inc. |
Benzisoxazole sulfonamide derivatives
|
|
US11591329B2
(en)
|
2019-07-09 |
2023-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
JP7721501B2
(ja)
|
2019-07-31 |
2025-08-12 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃｄ３８の阻害剤としてのヘテロ二環式アミド
|
|
RU2746423C2
(ru)
*
|
2019-09-02 |
2021-04-13 |
Общество с ограниченной ответственностью "Научно-исследовательский институт ХимРар" (ООО "НИИ ХимРар") |
Ингибитор вируса гепатита В (ВГВ)
|
|
US20220378756A1
(en)
|
2019-09-19 |
2022-12-01 |
Forma Therapeutics, Inc. |
Activating pyruvate kinase r
|
|
US12122767B2
(en)
|
2019-10-01 |
2024-10-22 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
WO2021076602A1
(en)
|
2019-10-14 |
2021-04-22 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
|
WO2021076728A1
(en)
|
2019-10-16 |
2021-04-22 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
|
EA202192047A1
(ru)
|
2019-11-13 |
2021-12-08 |
Юманити Терапьютикс, Инк. |
Соединения и их применение
|
|
JP7398840B2
(ja)
*
|
2019-11-14 |
2023-12-15 |
ジンキュア・コーポレイション |
Ａｍｐｋ抑制機能と亜鉛恒常性調節機能に基づく多発性硬化症治療用の薬学的組成物
|
|
KR20220131900A
(ko)
|
2019-12-04 |
2022-09-29 |
인사이트 코포레이션 |
Fgfr 억제제의 유도체
|
|
JP7720840B2
(ja)
|
2019-12-04 |
2025-08-08 |
インサイト・コーポレイション |
Ｆｇｆｒ阻害剤としての三環式複素環
|
|
CR20220316A
(es)
|
2019-12-06 |
2022-10-07 |
Vertex Pharma |
Tetrahidrofuranos sustituidos como moduladores de canales de sodio
|
|
US12012409B2
(en)
|
2020-01-15 |
2024-06-18 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
AR122711A1
(es)
|
2020-06-25 |
2022-09-28 |
Alchemedicine Inc |
COMPUESTO HETEROCÍCLICO COMO INHIBIDOR DE CASEÍNA QUINASA 1d Y/O QUINASA 5 TIPO RECEPTOR DE ACTIVINA
|
|
CA3191164A1
(en)
*
|
2020-08-10 |
2022-02-17 |
Dana-Farber Cancer Institute, Inc. |
Substituted 1,2,4-oxadiazoles as small molecule inhibitors of ubiquitin-specific protease 28
|
|
JP2023541463A
(ja)
*
|
2020-09-17 |
2023-10-02 |
ヤンセン ファーマシューティカ エヌ．ベー． |
カゼインキナーゼ１デルタモジュレーター
|
|
US11801243B2
(en)
|
2020-09-23 |
2023-10-31 |
Forma Therapeutics, Inc. |
Bromodomain inhibitors for androgen receptor-driven cancers
|
|
US11795168B2
(en)
|
2020-09-23 |
2023-10-24 |
Forma Therapeutics, Inc. |
Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)
|
|
WO2022175752A1
(en)
|
2021-02-19 |
2022-08-25 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
AU2022222470A1
(en)
|
2021-02-19 |
2023-09-21 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
US12128035B2
(en)
|
2021-03-19 |
2024-10-29 |
Novo Nordisk Health Care Ag |
Activating pyruvate kinase R
|
|
CA3215903A1
(en)
|
2021-04-12 |
2022-10-20 |
Incyte Corporation |
Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
|
|
CA3214215A1
(en)
*
|
2021-04-21 |
2022-10-27 |
Yunlong Song |
Imidazole-containing condensed ring derivative, preparation method therefor, and application thereof in medicine
|
|
JP2024522292A
(ja)
|
2021-06-04 |
2024-06-13 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ナトリウムチャネルのモジュレーターとしてのｎ－（ヒドロキシアルキル（ヘテロ）アリール）テトラヒドロフランカルボキサミド
|
|
EP4352059A1
(en)
|
2021-06-09 |
2024-04-17 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
WO2022261159A1
(en)
|
2021-06-09 |
2022-12-15 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
WO2023064133A1
(en)
*
|
2021-10-15 |
2023-04-20 |
Lomond Therapeutics, Inc. |
SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF
|
|
CN115466211B
(zh)
*
|
2022-06-09 |
2024-02-23 |
中国人民解放军空军军医大学 |
一种n-苯基喹啉-4-胺类化合物及其应用
|
|
JP2025525514A
(ja)
*
|
2022-07-14 |
2025-08-05 |
シャンハイ、レイジング、ファーマシューティカル、カンパニー、リミテッド |
Ｔｐｋアゴニスト及びそれを用いた神経変性疾患の治療方法
|
|
UY40374A
(es)
|
2022-08-03 |
2024-02-15 |
Novartis Ag |
Inhibidores de inflamasoma nlrp3
|
|
JP2025528595A
(ja)
*
|
2022-10-19 |
2025-08-28 |
長春金賽薬業有限責任公司 |
Ｎｋ３ｒアンタゴニストの結晶形及びその調製方法と用途
|
|
CN120917015A
(zh)
*
|
2023-01-20 |
2025-11-07 |
元启(苏州)生物制药有限公司 |
Srpk1抑制剂和使用方法
|
|
EP4660182A1
(en)
*
|
2023-01-30 |
2025-12-10 |
Eurofarma Laboratórios S.A. |
Nav1.7- and/or nav1.8-inhibiting aryl pyridine compounds, processes for the preparation thereof, compositions, uses, methods for treatment using same, and kits
|
|
AR131690A1
(es)
*
|
2023-01-30 |
2025-04-23 |
Eurofarma Laboratorios S A |
COMPUESTOS FENÓLICOS BLOQUEADORES DE Nav 1.7 Y/O Nav 1.8, SUS PROCESOS DE OBTENCIÓN, SUS COMPOSICIONES, SUS USOS, LOS MÉTODOS DE TRATAMIENTO DE LOS MISMOS Y LOS KITS
|
|
CN118666857B
(zh)
*
|
2024-06-26 |
2025-02-25 |
江西农业大学 |
一种喹啉类化合物及其在农用杀菌剂中的应用
|
|
CN119060061B
(zh)
*
|
2024-08-26 |
2025-09-16 |
浙江师范大学 |
一类苯并嘧啶硫醚类化合物作为sting蛋白小分子抑制剂的应用
|